scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203309345778 |
P698 | PubMed publication ID | 19933722 |
P50 | author | Eloisa Bonfa | Q37837127 |
Eduardo F Borba | Q56447325 | ||
P2093 | author name string | J B Lopes | |
R M R Pereira | |||
J Abe | |||
V F Caparbo | |||
G G Ribeiro | |||
E Gebrim | |||
R Sasdeli Neto | |||
P2860 | cites work | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Factors associated with coronary artery calcification in young female patients with SLE. | Q33188178 | ||
Accelerated atheroma in lupus--background | Q33915419 | ||
Systemic lupus erythematosus: a model for atherogenesis? | Q33922220 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function | Q34123475 | ||
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus | Q35552185 | ||
Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children | Q35638164 | ||
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis | Q36368706 | ||
Vascular calcification and osteoporosis--from clinical observation towards molecular understanding | Q36676122 | ||
Bone metabolism and vascular calcification | Q36777391 | ||
Vascular calcification in middle age and long-term risk of hip fracture: the Framingham Study | Q37356863 | ||
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). | Q40145477 | ||
Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus | Q40537191 | ||
Coronary calcium and cardiovascular event risk: evaluation by age- and sex-specific quartiles | Q40657316 | ||
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway | Q40752751 | ||
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 | ||
The effect of a single dose of osteoprotegerin in postmenopausal women | Q43520860 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. | Q44612340 | ||
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women | Q44774810 | ||
Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. | Q46771777 | ||
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. | Q51577475 | ||
Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. | Q51837371 | ||
Regional bone mineral density interrelationships in normal and osteoporotic postmenopausal women. | Q52304441 | ||
Quantification of coronary artery calcium using ultrafast computed tomography. | Q52867038 | ||
Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. | Q53270426 | ||
Menopause | Q56453537 | ||
P433 | issue | 1 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 27-33 | |
P577 | publication date | 2009-11-23 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients | |
P478 | volume | 19 |
Q36085018 | Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial. |
Q37960525 | Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus |
Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
Q34081242 | Cardiovascular involvement in autoimmune diseases |
Q45238173 | Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. |
Q33782750 | Inflammation and the osteogenic regulation of vascular calcification: a review and perspective |
Q38846584 | Menopause and Rheumatic Disease |
Q42073555 | Prevalence and possible risk factors of low bone mineral density in untreated female patients with systemic lupus erythematosus |
Q37822658 | Treatment of proliferative lupus nephritis: a slowly changing landscape |
Search more.